Secondary Malignancies | List of Frontiers open access articles

Original Research

Published on 07 Jul 2020

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk

in Radiation Oncology

Laila König
Peter Haering
Clemens Lang
Mona Splinter
Bastian von Nettelbladt
Fabian Weykamp
Philipp Hoegen
Jonathan W. Lischalk
Klaus Herfarth
Jürgen Debus

Frontiers in Oncology

doi 10.3389/fonc.2020.00989

5,559 views
26 citations

Mini Review

Published on 26 Nov 2015

Secondary Malignancy Risk Following Proton Radiation Therapy

in Radiation Oncology

Bree R. Eaton
Shannon M. MacDonald
Torunn I. Yock
Nancy J. Tarbell

Frontiers in Oncology

doi 10.3389/fonc.2015.00261

17,949 views
91 citations

Case Report

Published on 16 Jun 2023

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report

in Pharmacology of Anti-Cancer Drugs

Shuang Fu
Mengqi Li
Hongtao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141311

3,170 views
1 citation

Case Report

Published on 14 Nov 2022

Case report: Triple whammy: Synchronous radiotherapy induced glioblastoma multiforme and papillary thyroid cancer following nasopharyngeal carcinoma

in Neuro-Oncology and Neurosurgical Oncology

Kamalanathan Palaniandy
Zalikha Kamarudin
Yin Ping Wong
Shahizon Azura Mohamed Mukari
Winnie Xiao Hui Jiau
Azizi Abu Bakar

Frontiers in Oncology

doi 10.3389/fonc.2022.1012395

2,345 views
2 citations

Perspective

Published on 11 Apr 2024

A data-driven approach to improve wellness and reduce recurrence in cancer survivors

in Cancer Epidemiology and Prevention

Ramkumar Hariharan
Leroy Hood
Nathan D. Price

Frontiers in Oncology

doi 10.3389/fonc.2024.1397008

3,720 views
2 citations

Original Research

Published on 09 Jan 2024

Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019

in Cancer Epidemiology and Prevention

Tiemo Sven Gerber
Stephanie Strobl
Alexander Marx
Wilfried Roth
Stefan Porubsky

Frontiers in Oncology

doi 10.3389/fonc.2023.1308989

5,729 views
25 citations

Original Research

Published on 09 Dec 2021

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

in Pediatric Oncology

Long Dao
Dristhi Ragoonanan
Izhar Batth
Arun Satelli
Jessica Foglesong
Jian Wang
Wafik Zaky
Jonathan B. Gill
Diane Liu
Aisha Albert

Frontiers in Oncology

doi 10.3389/fonc.2021.760267

3,945 views
12 citations

Review

Published on 04 Mar 2025

CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?

in Cancer Immunity and Immunotherapy

Xueshuai Ye
Min Ge
Mengtian Tan
Yongqiang Wu
Haiqiang Zhang
Zexian Fu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1490491

6,286 views
5 citations

Original Research

Published on 04 Dec 2023

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

in Hematologic Malignancies

Baustin M. Welch
Bryce A. Manso
Kimberly A. Gwin
Petra K. Lothert
Sameer A. Parikh
Neil E. Kay
Kay L. Medina

Frontiers in Oncology

doi 10.3389/fonc.2023.1302038

3,036 views
2 citations

Case Report

Published on 24 Feb 2023

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

in Thoracic Oncology

Konstantin Shilo
Peter J. Kneuertz
David Liebner
Wei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1096160

1,550 views
1 citation

Case Report

Published on 17 Jun 2025

Case Report: Somatic malignancy classified as Wilms tumor arising within an immature teratoma

in Neuro-Oncology and Neurosurgical Oncology

Emily Muñoz
Cyrus Washington
Pasquale Benedetto
Ali Saad
Oleksandr N. Kryvenko
Dalissa Tejera
Macarena Ines De La Fuente
Michael Ivan
Gregory Azzam

Frontiers in Oncology

doi 10.3389/fonc.2025.1565865

1,620 views

Original Research

Published on 27 Nov 2023

Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

in Hematologic Malignancies

Lingling Wang
Conglin Xi
Yongfen Huang
Hao Xu
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1280033

2,006 views
2 citations

Case Report

Published on 27 Oct 2023

Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis

in Skin Cancer

Olga Bogomolets
Ewa Rojczyk
Roman Hryshchenko
Catherine Bogomolets
Oleksandr Berezkin

Frontiers in Oncology

doi 10.3389/fonc.2023.1265479

12,663 views
2 citations

Original Research

Published on 12 Apr 2024

Sleeve resection with end-to-end anastomosis in the reconstruction of tracheal defects exceeding six rings: a clinical feasibility study and safety assessment

in Otorhinolaryngology - Head and Neck Surgery

Xin Xia
Xiaoli Zhu
Yingying Zhu
Wenwen Diao
Xingming Chen

Frontiers in Surgery

doi 10.3389/fsurg.2023.1229522

2,459 views

Original Research

Published on 07 Oct 2021

90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary

in Molecular and Cellular Oncology

Yi Zhang
Lei Xia
Dawei Ma
Jing Wu
Xinyu Xu
Youtao Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.722808

5,787 views
14 citations

Study Protocol

Published on 06 Dec 2024

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

in Blood Cancer

Theo Leitner
Evgenii Shumilov
Christina Schwitlick
Raphael Koch
Franziska Hamm
Marion Högner
Florian Bassermann
Katja Weisel
Hermann Einsele
Martin Kortüm

Frontiers in Hematology

doi 10.3389/frhem.2024.1436845

2,417 views

Articles

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk

Secondary Malignancy Risk Following Proton Radiation Therapy

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report

Case report: Triple whammy: Synchronous radiotherapy induced glioblastoma multiforme and papillary thyroid cancer following nasopharyngeal carcinoma

A data-driven approach to improve wellness and reduce recurrence in cancer survivors

Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

Case Report: Somatic malignancy classified as Wilms tumor arising within an immature teratoma

Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis

Sleeve resection with end-to-end anastomosis in the reconstruction of tracheal defects exceeding six rings: a clinical feasibility study and safety assessment

90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)